 Good morning, I'm Dr Mohan Badgindi. I'm a consultant in diabetes and technology from Manipal Hospital Bangalore and I have over 35 years of experience in treating type 1, type 2 diabetes and complicated diabetes and I have been trained in United Kingdom in Edinburgh and Leeds and Newcastle upon time which is considered as a mecca of diabetes for Europe and Asia and to briefly give you an idea we are well versed with the modern management of type 1 diabetes, type 2 diabetes, GDM and obesity and as far as type 1 is concerned now we have most important is insulin analogs and long acting insulin available in Bangalore as well as in Manipal Hospital. We are very well versed with using insulin pumps and continuous glucose monitoring for our type 1 diabetes patients which has given us very good insight into the physiology and biochemistry of type 1 diabetes and we achieve very good results with CGMs and insulin adjustment in type 1 diabetes patients and as well as GDM is concerned that is the pregnancy induced type 2 type of diabetes we are very particular about providing good background education for pregnancy patients and we use very good insulin analogs which are available in our hospital and we monitor the blood glucose monitoring in type in this type of diabetes that is GDM and we get very good results in pregnancy induced diabetes. We normally train the pregnancy patients in how to monitor the glucose at home and then how to use insulin in our our patients department and whenever they are admitted for steroid therapy we also adjust their insulin dosage and we again train them in home monitoring of blood glucose sometimes we also advise them to use CGMs so that we can detect low blood sugar problems as well as high blood sugars associated with pregnancy and thus adjust the insulin dosage and when it comes to patients with type 2 diabetes who are undergoing surgery bypass or angioplasty coronary angiography peripheral angiography we always adjust the insulin dosage prior to the procedure and during the procedure and after the procedure for this we use one of the most advanced insulins that are recently introduced known as Fiaspa that is the fast acting as as part insulin which has been launched recently which is made available in our hospital which is a very short acting or ultra rapid acting insulin which works very well with long-acting insulins like glargin and terciba and use a very good results and very low incidence of hypoglycemia and very good levels of fasting as well as a post-prandial blood sugars and HVMNC levels now when it comes to post-prandial blood sugars we are very particular in controlling because that is considered as one of the markers of cardiovascular mortality and morbidity in type 2 diabetes patients and with the usage of Fiaspa and long-acting insulins we are able to hopefully achieve better results and control and reduce the cardiovascular mortality in our patient my message for world health is that we should use insulin early and control the blood sugars and improve the organ protection and reduce the cardiovascular mortality thus providing a good quality of life